Evidence map›Paper›PMID 41384910›Full record

ArticleApplied and environmental microbiology2026

A reverse transcription-quantitative polymerase chain reaction system for evaluating intestinal butyrate production by fecal bacteria.

Mai Hane, Kazuhito Shimamoto, Ryo Matsui, Kensuke Shimizu, Miyuki Katto, Takashi Asahara, Yoshiyuki Shishido, Takashi Kurakawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mai HaneYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.ORCID 0000-0002-9222-1753
Kazuhito ShimamotoYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Ryo MatsuiYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Kensuke ShimizuYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Miyuki KattoYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Takashi AsaharaYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Yoshiyuki ShishidoYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Takashi KurakawaYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.

Funding

Yakult Honsha
6 · The paper itself

Abstract

Intestinal butyrate is key in maintaining host health. As an indicator of butyrate production, the fecal butyrate concentration is used for assessing health status; however, it may not be a suitable marker as it only accounts for residual fecal butyrate following intestinal absorption. Therefore, we aimed to develop a novel quantitative system for evaluating intestinal butyrate production. We designed a primer set targeting the gene encoding butyryl-coenzyme A (CoA):acetate CoA-transferase (

Indexed as

BacteriaButyratesFecesGastrointestinal MicrobiomeIntestinesReverse Transcriptase Polymerase Chain ReactionBacterial ProteinsCoenzyme A-TransferasesHumansBacterial ProteinsButyratesCoenzyme A-Transferasesbutyratebutyryl-CoA:acetate CoA-transferasefecesmicrobiotaqPCRRT-qPCRsynbiotics

Identifiers

PMID41384910
PMCPMC12838319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.